0JS.F · MedMen Enterprises Inc

-

Please sign in to comment on 0JS.F

1 Comment

Admin

4 years ago

MedMen Enterprises Inc is currently in a long term downtrend where the price is trading 2.8% below its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.

MedMen Enterprises Inc's total revenue sank by 23.4% to $34M since the same quarter in the previous year.

Its net income has dropped by 22.4% to $-50M since the same quarter in the previous year.

Finally, its free cash flow grew by 68.7% to $-13M since the same quarter in the previous year.

Based on the above factors, MedMen Enterprises Inc gets an overall score of 2/5.

Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Exchange	F
CurrencyCode	EUR
ISIN	CA58507M1077

Market Cap	14M
PE Ratio	None
Target Price	None
Beta	1.43
Dividend Yield	None

ABOUT

MedMen Enterprises Inc

MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis retailer in the United States. The company provides products under the MedMen Red and LuxLyte brand names. As of June 25, 2022, it operated 19 stores in California, Nevada, Illinois, Arizona, and Massachusetts. MedMen Enterprises Inc. is based in Los Angeles, California.

0JS.F · MedMen Enterprises Inc

-

MedMen Enterprises Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest MedMen Enterprises Inc using a moving average strategy